The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy -Part 1
In part one of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss how Leber hereditary optic neuropathy (LHON) typically presents and outline the steps for diagnosing LHON in…
Read the full articleYou might also wanna read
Life Biosciences Conducts First Gene Therapy Trial to Reverse Cellular Aging in Patient with Glaucoma
For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable vision loss. The ris
popularmechanics.com·20d agoSafety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD)
Conditions : Leber Congenital Amaurosis; Leber Congenital Amaurosis (LCA); LCA5 Interventions : Drug: OPGx-RDH12 Sponsors : Opus Genetics, I
One-Time Gene Therapy Restores Vision in 6-Year-Old with Rare Congenital Blindness
Saffie Sandford from Stevenage was diagnosed with Leber's Congenital Amaurosis, (LCA) a mutation in the RPE 65 gene.
goodnewsnetwork.org·26d ago
Plasma proteomic signatures enable risk prediction of early retinal neurodegeneration in type 2 diabetes
In a observational multi-cohort study, Wei Wang and colleagues identify circulating plasma protein signatures of diabetic retinal neurodegen
plos.io·1mo ago
Hematopoietic stem cell gene therapy delivers cell-penetrating frataxin to treat Friedreich's ataxia in preclinical models
Engineered hematopoietic stem cells delivering a secreted, tissue-penetrating frataxin restore mitochondrial function and ameliorate disease
Life Biosciences Doses First Patient in FDA-Approved Gene Therapy Trial for Age-Related Blindness
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
gizmodo.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.